Quality of life assessment comes of age in the era of highly active antiretroviral therapy.
暂无分享,去创建一个
[1] D. Revicki,et al. Quality of life outcomes of combination zalcitabine-zidovudine, saquinavir-zidovudine, and saquinavir-zalcitabine-zidovudine therapy for HIV-infected adults with CD4 cell counts between 50 and 350 per cubic millimeter , 1999 .
[2] D. Patrick,et al. Strategies for Improving and Expanding the Application of Health Status Measures in Clinical Settings , 1992 .
[3] B. Sha. Combination Foscarnet and Ganciclovir Therapy vs. Monotherapy for the Treatment of Relapsed Cytomegalovirus Retinitis in Patients with AIDS: The Cytomegalovirus Retreatment Trial , 1996, Archives of ophthalmology.
[4] I Grant,et al. Quality of life in a placebo-controlled trial of zidovudine in patients with AIDS and AIDS-related complex. , 1990, Journal of acquired immune deficiency syndromes.
[5] R A Deyo,et al. Strategies for improving and expanding the application of health status measures in clinical settings. A researcher-developer viewpoint. , 1992, Medical care.
[6] J. Catalan,et al. Reliability and validity of an HIV-specific health-related quality-of-life measure for use with injecting drug users. , 1996, AIDS.
[7] K Henry,et al. The Case for More Cautious, Patient-Focused Antiretroviral Therapy , 2000, Annals of Internal Medicine.
[8] J. Catalan,et al. The reliability and validity of two HIV-specific health-related Quality-of-Life measures: a preliminary analysis. , 1993, AIDS.
[9] A. Wu,et al. Functional status and well-being in a placebo-controlled trial of zidovudine in early symptomatic HIV infection. , 1993, Journal of acquired immune deficiency syndromes.
[10] Roger Detels,et al. Plasma Viral Load and CD4+ Lymphocytes as Prognostic Markers of HIV-1 Infection , 1997, Annals of Internal Medicine.
[11] Albert Wu,et al. Comparison of Three Regimens for Treatment of Mild to Moderate Pneumocystis carinii Pneumonia in Patients with AIDS: A Double-Blind, Randomized Trial of Oral Trimethoprim-Sulfamethoxazole, Dapsone-Trimethoprim, and Clindamycin-Primaquine , 1996, Annals of Internal Medicine.
[12] D. Podzamczer,et al. A randomized study comparing instruments for measuring health-related quality of life in _HIV-infected patients , 1999 .
[13] J. Fahey,et al. Thalidomide for the treatment of oral aphthous ulcers in patients with human immunodeficiency virus infection. National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group. , 1997, The New England journal of medicine.
[14] H. Rubin,et al. A Health Status Questionnaire Using 30 Items From The Medical Outcomes Study: Preliminary Validation in Persons With Early HIV Infection , 1991, Medical care.
[15] P. Volberding,et al. Evaluation of the quality of life associated with zidovudine treatment in asymptomatic human immunodeficiency virus infection. The AIDS Clinical Trials Group. , 1994, The New England journal of medicine.
[16] J. Fahey,et al. Thalidomide for the treatment of esophageal aphthous ulcers in patients with human immunodeficiency virus infection. National Institute of Allergy and Infectious Disease AIDS Clinical Trials Group. , 1999, The Journal of infectious diseases.
[17] D. Podzamczer,et al. Evaluating changes in health status in HIV-infected patients: Medical Outcomes Study-HIV and Multidimensional Quality of Life-HIV quality of life questionnaires , 2000, AIDS.
[18] J. Fleishman,et al. Quality of Life in Persons with Human Immunodeficiency Virus Infection: Measurement by the Medical Outcomes Study Instrument , 1992, Annals of Internal Medicine.
[19] A. Wu. Response to Stewart and Nápoles-Springer: Quality-of-Life Assessment in Clinical Research: Application in Diverse Populations , 2000, Medical care.
[20] A. Antinori,et al. Disease-related factors associated with health-related quality of life in people with nonadvanced HIV disease assessed using an Italian version of the MOS-HIV Health Survey. , 1997, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.
[21] A. Wu,et al. Quality of life in asymptomatic- and symptomatic HIV infected patients in a trial of ritonavir/saquinavir therapy , 2000, AIDS.
[22] N. Duan,et al. Health Status and Function With Zidovudine or Zalcitabine as Initial Therapy for AIDS: A Randomized Controlled Trial , 1995 .
[23] D S Stein,et al. Within-subject variation in CD4 lymphocyte count in asymptomatic human immunodeficiency virus infection: implications for patient monitoring. , 1994, The Journal of infectious diseases.